Constitutive NF-κB activation has been reported in different kinds of tumors [172,173]; more importantly, high levels of NF-κB activation have been found in tumor samples from lung cancer patients, both for SCLC and NSCLC, and it is associated with poor prognosis [173,174]. This evidence concerns the gene NFKB1 and small cell lung carcinoma.